Edwards Lifesciences Corporation Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

EW

Κατάταξη σε μετοχές #482
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Τιμή μετοχής
$87.68
Κεφαλαιοποίηση
$50.54B
Αλλαγή (1 ημέρα)
0.45%
Αλλαγή (1 έτος)
16.46%
Χώρα
US
Εμπόριο Edwards Lifesciences Corporation (EW)

Κατηγορία

Healthcare
Ιστορικό διασπάσεων μετοχών για Edwards Lifesciences Corporation (EW)
Η μετοχή Edwards Lifesciences Corporation (σύμβολο: EW) υπέστη συνολικά 3 διασπάσεις.
Η πιο πρόσφατη διάσπαση πραγματοποιήθηκε στις Jun 01, 2020.
Μία μετοχή EW που αγοράστηκε πριν τις May 28, 2010 ισοδυναμεί σήμερα με 12 μετοχές EW.
Λίστα διασπάσεων μετοχών
Έτος Διάσπαση Πολλαπλασιαστής Αθροιστικός Πολλαπλασιαστής
2020-06-01 3:1 x3 x12
2015-12-14 2:1 x2 x4
2010-05-28 2:1 x2 x2
Διασπάσεις μετοχών για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Αριθμός διασπάσεων μετοχών Αθροιστικός Πολλαπλασιαστής Χώρα
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE